Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Arthur Pancioli"'
Autor:
Boryana Stamova, Glen C Jickling, Bradley P Ander, Xinhua Zhan, DaZhi Liu, Renee Turner, Carolyn Ho, Jane C Khoury, Cheryl Bushnell, Arthur Pancioli, Edward C Jauch, Joseph P Broderick, Frank R Sharp
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102550 (2014)
Epidemiological studies suggest that sex has a role in the pathogenesis of cardioembolic stroke. Since stroke is a vascular disease, identifying sexually dimorphic gene expression changes in blood leukocytes can inform on sex-specific risk factors, r
Externí odkaz:
https://doaj.org/article/a685a8f1918440319b70355b178387d4
Autor:
Hajar Amini, Bodie Knepp, Fernando Rodriguez, Paulina Carmona, Jane C Khoury, Arthur Pancioli, Joseph P Broderick, Bradley Ander, Frank R Sharp, Boryana Stamova
Publikováno v:
Stroke. 53
Objective: Prediction of the long-term outcome in Ischemic Stroke (IS) patients can have a significant impact on design of clinical trials and on patients’ care. We studied gene expression (GE) as a novel biomarker to provide an accurate prediction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80b37cb1d117645f7852893eac745826
https://doi.org/10.1161/str.53.suppl_1.wp251
https://doi.org/10.1161/str.53.suppl_1.wp251
Autor:
Danielle Cornwall, Jane Khoury, Arthur Pancioli, Pamela Schmit, Heidi Sucharew, Joseph Broderick, Opeolu Adeoye
Publikováno v:
Stroke. 47
Background: The Combined approach to Lysis utilizing Eptifibatide And Rt-PA in Acute Ischemic Stroke (CLEAR), CLEAR-Enhanced Regimen (CLEAR-ER) and CLEAR-Full Dose Regimen (CLEAR-FDR) trials were phase 2 trials that examined escalating doses of recom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21177b0f32661171a3b32d8c96dd3f13
https://doi.org/10.1161/str.47.suppl_1.182
https://doi.org/10.1161/str.47.suppl_1.182
Autor:
Ariyan Javadi, Opeolu Adeoye, Jane Khoury, Heidi Sucharew, Pamela Schmit, Thomas Tomsick, Arthur Pancioli
Publikováno v:
Stroke. 45
Trial Introduction/Purpose: The C ombined Approach to L ysis Utilizing E ptifibatide and r t-PA in Acute Ischemic Stroke- E nhanced R egimen (CLEAR-ER) trial demonstrated the safety of a reduced-dose rtPA regimen (0.6mg/kg rt-PA over 40 minutes) plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6355199f0bd567f7136b2430e9e91a2
https://doi.org/10.1161/str.45.suppl_1.tmp17
https://doi.org/10.1161/str.45.suppl_1.tmp17
Autor:
Opeolu Adeoye, Heidi Sucharew, Jane Khoury, Pamela Schmit, Thomas M Hemmen, Brett C Meyer, Joseph Broderick, Arthur Pancioli
Publikováno v:
Stroke. 45
Background: The proportion of good outcome (modified Rankin score/mRS ≤1 or return to baseline mRS) in the intervention arm of the randomized Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke-Enhanced Regimen (CLE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdb5f2fd0dbc1edff9944aec4308fc0f
https://doi.org/10.1161/str.45.suppl_1.tp199
https://doi.org/10.1161/str.45.suppl_1.tp199
Autor:
Aaron M Anderson, Jane C Khoury, Eric Rademacher, Brett M Kissela, Daniel Woo, Matthew L Flaherty, Pooja Khatri, Opeolu Adeoye, Simona Ferioli, Arthur Pancioli, Joseph P Broderick, Dawn O Kleindorfer
Publikováno v:
Stroke. 45
Introduction: Delay in seeking medical attention after stroke symptom onset is the most common reason for low rates of thrombolytic use for ischemic stroke. This may be related to poor recognition of stroke symptoms or lack of awareness of time-sensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d6625981eb7aa44b2ff90a8fb88c7d5
https://doi.org/10.1161/str.45.suppl_1.tmp72
https://doi.org/10.1161/str.45.suppl_1.tmp72
Autor:
Thomas A. Tomsick, Joseph P. Broderick, Brett M. Kissela, Edward C. Jauch, Judith Spilker, Matthew L. Flaherty, Janice Carrozzella, Arthur Pancioli, Padmini Sekar, D. Woo
Publikováno v:
Scopus-Elsevier
Combined IV and intra-arterial (IA) thrombolysis for acute ischemic stroke may offer advantages over either technique alone. Sixty-two nonrandomized patients with NIH Stroke Scale scores ofor =10 who met standard criteria for IV thrombolysis were tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46eb9508ace7c6af756c729c2cd8a5f
https://doi.org/10.1212/01.wnl.0000149529.78396.b0
https://doi.org/10.1212/01.wnl.0000149529.78396.b0
Autor:
Amy K Guzik, Rema Raman, Karin Ernstrom, Dawn M Meyer, Thomas Hemmen, Arthur Pancioli, Brett C Meyer
Publikováno v:
Stroke. 44
Background: Advanced age and high NIHSS are independent predictors of poor AIS outcome. While not excluded from IV rtPA, response is debated in these groups. Patients in the “STROKE 100 Club” (AIS with any combination of age + NIHSS ≥100) have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daaf8d27ceae1c01982eb99ceb631de9
https://doi.org/10.1161/str.44.suppl_1.awp59
https://doi.org/10.1161/str.44.suppl_1.awp59
Autor:
Glen C Jickling, Boryana Stamova, Bradley P Ander, Xinhua Zhan, DaZhi Liu, Piero Verro, Jane Khoury, Edward C Jauch, Arthur Pancioli, Joseph P Broderick, Frank R Sharp
Publikováno v:
Stroke. 44
Background: Hemorrhagic transformation (HT) is a major complication of ischemic stroke that worsens outcomes and increases mortality. In ischemic stroke circulating leukocytes may contribute to blood brain barrier disruption, which is an important co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::178e7d67fb26aed7a2c66c6f05ffc1ab
https://doi.org/10.1161/str.44.suppl_1.atp215
https://doi.org/10.1161/str.44.suppl_1.atp215